Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease

American Journal of Kidney Diseases

Volumn 47, Issue 1, 2006, Pages

  Hiyama, Lauren ^b   Tang, Angela ^b   Miller, Loren G ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

Autosomal dominant polycystic kidney disease (ADPKD); Group B streptococcus; Levofloxacin; Pyocyst; Renal cyst

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; NITROFURANTOIN; PENICILLIN G; VANCOMYCIN;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD CULTURE; CASE REPORT; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG TUMOR LEVEL; FEMALE; GRAM POSITIVE BACTERIUM; HEMODIALYSIS; HUMAN; KIDNEY CYST; KIDNEY INFECTION; KIDNEY POLYCYSTIC DISEASE; PYELONEPHRITIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SURGICAL DRAINAGE; TREATMENT OUTCOME; URINE CULTURE;

ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; OFLOXACIN; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PYELONEPHRITIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 29244432187     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.09.021     Document Type: Article

References (13)

1. P.A. Gabow Autosomal dominant polycystic kidney disease N Engl J Med 329 1993 332 342
2. A.H. Sklar, R.J. Caruana, J.E. Lammers, G.D. Strauser Renal infections in autosomal dominant polycystic kidney disease Am J Kidney Dis 10 1987 81 88
3. A.B. Chapman, D. Thickman, P.A. Gabow Percutaneous cyst puncture in the treatment of cyst infection in autosomal dominant polycystic kidney disease Am J Kidney Dis 16 1990 252 255
4. W.M. Bennett, L. Elzinga, J.P. Pulliam, A.L. Rashad, J.M. Barry Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease Am J Kidney Dis 6 1985 400 404
5. P. Gibson, M.L. Watson Cyst infection in polycystic kidney disease A clinical challenge Nephrol Dial Transplant 13 1998 2455 2457
6. R.S. Muther, W.M. Bennett Cyst fluid antibiotic concentrations in polycystic kidney disease Difference between proximal and distal cysts Kidney Int 20 1981 519 522
7. S. Schwab, D. Hinthorn, D. Diedrich, F. Cuppage, J. Grantham pH-Dependent accumulation of clindamycin in a polycystic kidney Am J Kidney Dis 3 1983 63 66
8. M.E. Ernst, E.J. Ernst, M.E. Klepser Levofloxacin and trovafloxacin The next generation of fluoroquinolones? Am J Health Syst Pharm 54 1997 2569 2584
9. L.W. Elzinga, T.A. Golper, A.L. Rashad, M.E. Carr, W.M. Bennett Ciprofloxacin activity in cyst fluid from polycystic kidneys Antimicrob Agents Chemother 32 1988 844 847
10. S.J. Rossi, D.P. Healy, D.V. Savani, G. Deepe High-dose ciprofloxacin in the treatment of a renal cyst infection Ann Pharmacol 27 1993 38 39
11. L.J. Piddock, M.M. Johnson Accumulation of 10 fluoroquinolones by wild-type orefflux mutant Streptococcus pneumoniae Antimicrob Agents Chemother 46 2002 813 820
12. S. Gupta, A. Seith, K. Sud CT in the evaluation of complicated autosomal dominant polycystic kidney disease Acta Radiol 41 2000 280 284
13. H. Stass, A. Dalhoff, D. Kubitza, U. Schuhly Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects Antimicrob Agents Chemother 42 1998 2060 2065